Treatment with metformin was associated with a reduction in asthma attacks among patients with asthma and type 2 diabetes, with additional reductions observed with the use of GLP-1 receptor agonists, ...
The Chronic Disease Management Market size is expected to reach USD 5.7 billion by 2024 and is further anticipated to reach USD 18.4 billion by 2033 according to Dimension Market Research. The market ...
Dr Lutz Beckert, Professor of Medicine at the University of Otago and a respiratory specialist with Te Whatu Ora Canterbury says the new COPD Clinical Care Standard, which was launched last month by ...